Find a Tender · Contract
Pathology Rapid PCR testing systems,reagents & maintenance
A public procurement published by Salisbury NHS Foundation Trust via Find a Tender.
- £516k
- Award value
- —
- Tender value
- 2
- Suppliers
- 2
- Awards
- 3
- Notices
- Contract
- Stage
Overview
Pathology Rapid polymerase chain reaction (PCR) Testing System Maintenance and Reagents GS 10997 CSS EO 1221
Key details
- Source
- Find a Tender
- Lifecycle stage
- Contract
- Status
- complete
- CPV classification
- —
- Currency
- GBP
- Total award value
- £516,000
- Tender value
- —
- First published
- 28 Oct 2025
- Last updated
- 17 Dec 2025
Awards
2 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| CEPHEID UK LIMITED | 04422108 | — | active | — |
| Cepheid UK Limited | 04422108 | — | pending | £516k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Salisbury NHS Foundation Trust
FAQs about this procurement
Who is the buyer for "Pathology Rapid PCR testing systems,reagents & maintenance"?
Pathology Rapid PCR testing systems,reagents & maintenance is a UK public-sector procurement published by Salisbury NHS Foundation Trust via Find a Tender.
Has "Pathology Rapid PCR testing systems,reagents & maintenance" been awarded?
Yes — 2 awards are recorded, with a reported total value of £516,000. The current lifecycle stage is "Contract".
Which suppliers are involved in "Pathology Rapid PCR testing systems,reagents & maintenance"?
2 suppliers are linked: CEPHEID UK LIMITED, Cepheid UK Limited.
What is "Pathology Rapid PCR testing systems,reagents & maintenance" worth?
The reported award value is £516,000.
When was "Pathology Rapid PCR testing systems,reagents & maintenance" published?
It was first published on 28 Oct 2025 and last updated on 17 Dec 2025, across 3 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable